Back
Control COVID-19 Spread
Published 2020-03-18
With the threat of the COVID-19 global pandemic being so significant and devastating to those affected around the world, WellAir has received many inquiries regarding the effectiveness of our portable air dis-infection solutions to reduce the spread of the virus.
It has been determined that the highly-contagious COVID-19 can be spread through coughing, sneezing, and secretions.
WellAir air dis-infection units can assist in reducing the chances of contracting COVID-19 by airborne methods when the units are used properly.
WellAir air dis-infection units can assist in reducing the chances of contracting COVID-19 by airborne methods when the units are used properly.
The COVID-19 pandemic is a tragedy for all affected. We hope that the concerted efforts and guidelines followed will soon show results and combat this rapidly-spreading coronavirus.
WellAir's Novaerus technology has been shown to reduce MS2 Bacteriophage, a commonly used surrogate for SARS-CoV* (Coronavirus) up to 99.99%
The table below shows the range of viruses we have tested, along with the common surrogates associated with each virus:
Below are some important points about WellAir's Novaerus viral testing.
- Novaerus technology has been independently tested against a range of viruses, showing consistent kill rates across both enveloped and non-enveloped strains.
- There are many different types of viruses in existence due to the variety of genomic structures. Viruses contain more structural genomic diversity than plants, animals, archaea, or bacteria.
- It is not possible for us to test against all types of viruses. We have, therefore, selected to test a range of viruses that are pathogenic to humans. We have also selected certain viruses that act as surrogates for other viruses that are too dangerous to be tested. These include enveloped and non-enveloped classes.
- Our patented plasma rapidly destroys pathogens using a combination of physical reactions (electroporation, electron bombardment, etching, etc.). This has been tested and proven in independent testing carried out by the NASA Ames Research Centre, California.
- This process is not selective in its destruction. Given the rapid and consistent kill rates achieved using Novaerus, it is reasonable to anticipate that our plasma technology will show a similar impact and rapid kill rates across all viral particles.
- Due to the small size of viruses, many filtration technologies are unable to trap viral particles. As Novaerus is a non-selective, rapid killing technology, it offers a unique and safe solution to kill airborne viruses 24/7, reducing the risk of disease and infectious outbreaks.
*(2010 - Evaluation of filters for the sampling and quantification of RNA Phage Aerosols, Louis Gendron et al.)
Novaerus units use non-chemical, ultra-low energy, plasma technology, which is powerful enough to destroy viruses and pathogens on contact, yet gentle enough for continued use around patients and staff.
Contact a WellAir representative to learn more about how our solutions can help battle viral outbreaks info@wellairsolutions.com.
